Postmenopausal osteoporosis: therapeutic options.
Genazzani
A R
AR
Department of Gynecology and Obstetrics, University of Pisa, Italy.
Gambacciani
M
M
Schneider
H P G
HP
Christiansen
C
C
D000367:Age Factors; D045930:Anabolic Agents / Q000008:administration & dosage; D000818:Animals; D015519:Bone Density; D002118:Calcium / Q000008:administration & dosage; D003276:Contraceptives, Oral / Q000009:adverse effects; D004164:Diphosphonates / Q000008:administration & dosage; D004195:Disease Models, Animal; D015914:Estrogen Replacement Therapy / Q000379:methods; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D009652:Norpregnenes / Q000008:administration & dosage; D009942:Organometallic Compounds / Q000008:administration & dosage; D015663:Osteoporosis, Postmenopausal / Q000235:genetics / Q000517:prevention & control* / Q000628:therapy*; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage; D016103:Spinal Fractures / Q000175:diagnosis / Q000209:etiology; D013876:Thiophenes / Q000008:administration & dosage; D014807:Vitamin D / Q000008:administration & dosage
D045930:Anabolic Agents; D003276:Contraceptives, Oral; D004164:Diphosphonates; D009652:Norpregnenes; D009942:Organometallic Compounds; D020845:Selective Estrogen Receptor Modulators; D013876:Thiophenes; C081587:strontium ranelate; D014807:Vitamin D; C027385:tibolone; D002118:Calcium